Home/Eikon Therapeutics/Dr. Eric T. Wang
DE

Dr. Eric T. Wang

Chief Scientific Officer

Eikon Therapeutics

Therapeutic Areas

Eikon Therapeutics Pipeline

DrugIndicationPhase
EIK-001Oncology (Undisclosed)Preclinical
EIK-002Immunology/Inflammation (Undisclosed)Preclinical
EIK-003Oncology (Undisclosed)Discovery
EIK-004UndisclosedDiscovery
EIK-005UndisclosedDiscovery